Preliminary results from an interim analysis of a vaccine trial in Guinea show that a new vaccine is highly effective against the deadly Ebola that claimed the lives of thousands. The independent body of international experts – the Data and Safety Monitoring Board – that conducted the review, advised that the trial of VSV-EBOV (Merck, Sharp & Dohme) should continue. Preliminary results from anal